Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Immunotherapy Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Immunotherapy Market Status and Forecast (2016-2027)
      • 1.3.2 Global Immunotherapy Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Immunotherapy Supply by Company

    • 2.1 Global Immunotherapy Sales Value by Company
    • 2.2 Immunotherapy Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Immunotherapy Market Status by Category

    • 3.1 Immunotherapy Category Introduction
      • 3.1.1 Monoclonal Antibodies
      • 3.1.2 Therapeutic Vaccines
      • 3.1.3 Checkpoint Inhibitors
      • 3.1.4 Non-Specific Immunotherapy
    • 3.2 Global Immunotherapy Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Immunotherapy Market Status by End User/Segment

    • 4.1 Immunotherapy Segment by End User/Segment
      • 4.1.1 Oncology
      • 4.1.2 Inflammation
      • 4.1.3 Central Nervous System
      • 4.1.4 Others
    • 4.2 Global Immunotherapy Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Immunotherapy Market Status by Region

    • 5.1 Global Immunotherapy Market by Region
    • 5.2 North America Immunotherapy Market Status
    • 5.3 Europe Immunotherapy Market Status
    • 5.4 Asia Pacific Immunotherapy Market Status
    • 5.5 Central & South America Immunotherapy Market Status
    • 5.6 Middle East & Africa Immunotherapy Market Status

    6 North America Immunotherapy Market Status

    • 6.1 North America Immunotherapy Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Immunotherapy Market Status

    • 7.1 Europe Immunotherapy Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Immunotherapy Market Status

    • 8.1 Asia Pacific Immunotherapy Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Immunotherapy Market Status

    • 9.1 Central & South America Immunotherapy Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Immunotherapy Market Status

    • 10.1 Middle East & Africa Immunotherapy Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Immunotherapy Market Forecast by Category and by End User/Segment

    • 12.1 Global Immunotherapy Sales Value Forecast (2022-2027)
    • 12.2 Global Immunotherapy Forecast by Category
    • 12.3 Global Immunotherapy Forecast by End User/Segment

    13 Global Immunotherapy Market Forecast by Region/Country

    • 13.1 Global Immunotherapy Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Roche
      • 14.1.1 Company Information
      • 14.1.2 Immunotherapy Product Introduction
      • 14.1.3 Roche Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Pfizer
      • 14.2.1 Company Information
      • 14.2.2 Immunotherapy Product Introduction
      • 14.2.3 Pfizer Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Novartis
      • 14.3.1 Company Information
      • 14.3.2 Immunotherapy Product Introduction
      • 14.3.3 Novartis Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Merck
      • 14.4.1 Company Information
      • 14.4.2 Immunotherapy Product Introduction
      • 14.4.3 Merck Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Johnson & Johnson
      • 14.5.1 Company Information
      • 14.5.2 Immunotherapy Product Introduction
      • 14.5.3 Johnson & Johnson Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Celgene
      • 14.6.1 Company Information
      • 14.6.2 Immunotherapy Product Introduction
      • 14.6.3 Celgene Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Bristol-Myers Squibb
      • 14.7.1 Company Information
      • 14.7.2 Immunotherapy Product Introduction
      • 14.7.3 Bristol-Myers Squibb Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Biogen
      • 14.8.1 Company Information
      • 14.8.2 Immunotherapy Product Introduction
      • 14.8.3 Biogen Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Amgen, Inc.
      • 14.9.1 Company Information
      • 14.9.2 Immunotherapy Product Introduction
      • 14.9.3 Amgen, Inc. Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Abbvie
      • 14.10.1 Company Information
      • 14.10.2 Immunotherapy Product Introduction
      • 14.10.3 Abbvie Immunotherapy Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Immunotherapy market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Immunotherapy market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Monoclonal Antibodies
      Therapeutic Vaccines
      Checkpoint Inhibitors
      Non-Specific Immunotherapy

      Segmented by End User/Segment
      Oncology
      Inflammation
      Central Nervous System
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Roche
      Pfizer
      Novartis
      Merck
      Johnson & Johnson
      Celgene
      Bristol-Myers Squibb
      Biogen
      Amgen, Inc.
      Abbvie
      Buy now